July 16 (Reuters) - Abbott Laboratories on Thursday reported a 46.6% fall in second-quarter profit as the COVID-19 pandemic continued to batter its medical device unit.
The company’s net earnings fell to $$537 million, or 30 cents per share, in the quarter ended June 30, from $1 billion, or 56 cents per share, a year earlier.
Net sales fell to $7.33 billion from $7.98 billion. (Reporting by Trisha Roy and Manojna Maddipatla in Bengaluru; Editing by Maju Samuel)
Our Standards: The Thomson Reuters Trust Principles.